Vulnerability Details : CVE-2017-18228
Remedy Mid Tier in BMC Remedy AR System 9.1 allows XSS via the ATTKey parameter in an arsys/servlet/AttachServlet request.
Vulnerability category: Cross site scripting (XSS)
Products affected by CVE-2017-18228
- cpe:2.3:a:bmc:remedy_action_request_system:*:*:*:*:*:*:*:*
Exploit prediction scoring system (EPSS) score for CVE-2017-18228
0.05%
Probability of exploitation activity in the next 30 days
EPSS Score History
~ 21 %
Percentile, the proportion of vulnerabilities that are scored at or less
CVSS scores for CVE-2017-18228
Base Score | Base Severity | CVSS Vector | Exploitability Score | Impact Score | Score Source | First Seen |
---|---|---|---|---|---|---|
3.5
|
LOW | AV:N/AC:M/Au:S/C:N/I:P/A:N |
6.8
|
2.9
|
NIST | |
5.4
|
MEDIUM | CVSS:3.0/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N |
2.3
|
2.7
|
NIST |
CWE ids for CVE-2017-18228
-
The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users.Assigned by: nvd@nist.gov (Primary)
References for CVE-2017-18228
-
https://communities.bmc.com/thread/164169
XSS vulnerability with BMC Remedy Web-Mid Tier ... | BMC CommunitiesVendor Advisory
Jump to